Articles
Source: SITEMAN Cancer Center, Julia Evangelou Strait, June 2021.
Source: BIOCENTURY Wugen: deploying memory NK cells against cancer AND TURNING ALLOGENEIC CAR T CELLS AGAINST T CELL MALIGNANCIES BY LAUREN MARTZ, …
Currently approved cellular therapies have been shown to effectively treat B-cell cancers, but there remains a significant unmet need for treating other cancers, including solid tumors.
Technology Networks, Ryan Sullivan, Wugen, March 2021
St. Louis Business Journal, Nathan Rubbelke, March 2021
St. Louis Business Journal, Nathan Rubbelke, February 2021
Biospace, Kate Goodwin, January 2021
Latest News
The Woodlands, TX, and St. Louis, MO, March 14, 2024/ Cision / – Cellipont Bioservices, …
Wugen to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its programs for …
— Dr. Vendola Brings Deep, Hands-On Industry Strategy, Operational and Financial Expertise to the …
Next in our story
Copyright © 2024 Wugen. All Rights Reserved.
a COGNEO design